These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11364367)

  • 21. Changes in viral load in people with virological failure who remain on the same HAART regimen.
    Cozzi-Lepri A; Phillips AN; Miller V; Katlama C; Ledergerber B; Vella S; Weber J; Bruun JN; Kirk O; Clotet B; Lundgrens JD
    Antivir Ther; 2003 Apr; 8(2):127-36. PubMed ID: 12741625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapy.
    Navarrete P; Morente V; García F; Alós L; Arnedo M; Plana M; Gil C; Caballero M; Miró JM; Martínez E; Fumero E; Castro P; Blanco JL; Mallolas J; Blanch JL; Cruceta A; Mestre G; Pumarola T; Gallart T; Gatell JM
    Antivir Ther; 2003 Dec; 8(6):635-7. PubMed ID: 14760898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidance offered in drug combination choices.
    AIDS Alert; 1997 Dec; 12(12):135-7. PubMed ID: 11364831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.
    Sanchez R; Portilla J; Gimeno A; Boix V; Llopis C; Sanchez-Paya J; Merino E; de la Sen ML; Muñoz C; Reus S; Plazas J
    J Infect; 2007 Feb; 54(2):159-66. PubMed ID: 16690132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Viral load and monitoring of antiretroviral treatment].
    Soriano V; Mas A; Gómez-Cano M; Villalba N; Bravo R; González-Lahoz J
    Rev Clin Esp; 1996 Dec; 196(12):872-7. PubMed ID: 9132868
    [No Abstract]   [Full Text] [Related]  

  • 26. Symptom-reduction trials at FDA clinical trials workshop. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Sep; (no 231):7. PubMed ID: 11362873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
    Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
    Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDA notifications. NRTI Emtriva receives FDA approval.
    AIDS Alert; 2003 Oct; 18(10):131-2. PubMed ID: 14686301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.
    Bossi P; Peytavin G; Ait-Mohand H; Delaugerre C; Ktorza N; Paris L; Bonmarchand M; Cacace R; David DJ; Simon A; Lamotte C; Marcelin AG; Calvez V; Bricaire F; Costagliola D; Katlama C
    HIV Med; 2004 Sep; 5(5):352-9. PubMed ID: 15369510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.
    Jacobson JM; Pat Bucy R; Spritzler J; Saag MS; Eron JJ; Coombs RW; Wang R; Fox L; Johnson VA; Cu-Uvin S; Cohn SE; Mildvan D; O'Neill D; Janik J; Purdue L; O'Connor DK; Vita CD; Frank I;
    J Infect Dis; 2006 Sep; 194(5):623-32. PubMed ID: 16897661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
    Landman R; Capitant C; Descamps D; Chazallon C; Peytavin G; Katlama C; Pialoux G; Bentata M; Brun-Vézinet F; Aboulker JP; Yéni P;
    J Antimicrob Chemother; 2009 Jul; 64(1):118-25. PubMed ID: 19420019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
    Persaud D; Palumbo P; Ziemniak C; Chen J; Ray SC; Hughes M; Havens P; Purswani M; Gaur AH; Chadwick EG;
    J Infect Dis; 2007 May; 195(10):1402-10. PubMed ID: 17436219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral rounds. Virologic failure: true or false?
    Gallant JE; Shafer R
    AIDS Clin Care; 2005 Sep; 17(9):84-5. PubMed ID: 16201048
    [No Abstract]   [Full Text] [Related]  

  • 34. Maintaining antiretroviral therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and profound immunodeficiency.
    Kousignian I; Abgrall S; Grabar S; Mahamat A; Teicher E; Rouveix E; Costagliola D;
    Clin Infect Dis; 2008 Jan; 46(2):296-304. PubMed ID: 18171266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-daily dosing of nevirapine in HAART.
    Clotet B
    J Antimicrob Chemother; 2008 Jan; 61(1):13-6. PubMed ID: 18006524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA notifications. New guidance assists HIV drug development. Changes affect approvals for antiretroviral drugs.
    AIDS Alert; 2003 Jan; 18(1):10-1. PubMed ID: 12541998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy and safety of protease inhibitor switching to nevirapine in HIV-infected patients with undetectable virus load.
    Gil P; de Górgolas M; Estrada V; Arranz A; Rivas P; Yera C; García R; Granizo JJ; Fernández-Guerrero M
    Clin Infect Dis; 2004 Oct; 39(7):1024-9. PubMed ID: 15472856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
    Narciso P; Lazzarin A
    Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent developments in HIV treatment, Part 2.
    Boyle BA
    AIDS Read; 2005 Jun; 15(6):277-9, 284. PubMed ID: 15962449
    [No Abstract]   [Full Text] [Related]  

  • 40. Editorial: time to end the death trials.
    James JS
    AIDS Treat News; 1996 Aug; (no 252):1-4. PubMed ID: 11363751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.